A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
Ehlers-Danlos syndrome
dyspnea
respiratory health
Journal
Chronic respiratory disease
ISSN: 1479-9731
Titre abrégé: Chron Respir Dis
Pays: England
ID NLM: 101197408
Informations de publication
Date de publication:
Historique:
entrez:
22
7
2021
pubmed:
23
7
2021
medline:
4
11
2021
Statut:
ppublish
Résumé
Ehlers-Danlos Syndromes (EDS) and Hypermobility Spectrum Disorders (HSD) are a heterogeneous group of heritable genetic connective tissue disorders with multiple characteristics including joint hypermobility, tissue fragility, and multiple organ dysfunction. Respiratory manifestations have been described in EDS patients, but have not been systematically characterized. A narrative review was undertaken to describe the respiratory presentations and management strategies of individuals with EDS and HSD. A broad literature search of Medline, Embase, Cochrane Database of Systematic Reviews, and Cochrane CENTRAL was undertaken from inception to November 2020 of all study types, evaluating EDS/ HSD and pulmonary conditions. This narrative review was limited to adult patients and publications in English. Respiratory manifestations have generally been described in hypermobile EDS (hEDS), classical and vascular EDS subtypes. Depending on EDS subtype, they may include but are not limited to dyspnea, dysphonia, asthma, sleep apnea, and reduced respiratory muscle function, with hemothorax and pneumothorax often observed with vascular EDS. Respiratory manifestations in HSD have been less frequently characterized in the literature, but exertional dyspnea is the more common symptom described. Respiratory symptoms in EDS can have an adverse impact on quality of life. The respiratory management of EDS patients has followed standard approaches with thoracotomy tubes and pleurodesis for pleural manifestations, vocal cord strengthening exercises, continuous positive pressure support for sleep apnea, and exercise training. Reduced respiratory muscle function in hEDS patients responds to inspiratory muscle training. Respiratory symptoms and manifestations are described in EDS and HSD, and have generally been managed using conservative non-surgical strategies. Research into the prevalence, incidence and specific respiratory management strategies in EDS and HSD is needed to mitigate some of the associated morbidity.
Sections du résumé
BACKGROUND
Ehlers-Danlos Syndromes (EDS) and Hypermobility Spectrum Disorders (HSD) are a heterogeneous group of heritable genetic connective tissue disorders with multiple characteristics including joint hypermobility, tissue fragility, and multiple organ dysfunction. Respiratory manifestations have been described in EDS patients, but have not been systematically characterized. A narrative review was undertaken to describe the respiratory presentations and management strategies of individuals with EDS and HSD.
METHODS
A broad literature search of Medline, Embase, Cochrane Database of Systematic Reviews, and Cochrane CENTRAL was undertaken from inception to November 2020 of all study types, evaluating EDS/ HSD and pulmonary conditions. This narrative review was limited to adult patients and publications in English.
RESULTS
Respiratory manifestations have generally been described in hypermobile EDS (hEDS), classical and vascular EDS subtypes. Depending on EDS subtype, they may include but are not limited to dyspnea, dysphonia, asthma, sleep apnea, and reduced respiratory muscle function, with hemothorax and pneumothorax often observed with vascular EDS. Respiratory manifestations in HSD have been less frequently characterized in the literature, but exertional dyspnea is the more common symptom described. Respiratory symptoms in EDS can have an adverse impact on quality of life. The respiratory management of EDS patients has followed standard approaches with thoracotomy tubes and pleurodesis for pleural manifestations, vocal cord strengthening exercises, continuous positive pressure support for sleep apnea, and exercise training. Reduced respiratory muscle function in hEDS patients responds to inspiratory muscle training.
CONCLUSION
Respiratory symptoms and manifestations are described in EDS and HSD, and have generally been managed using conservative non-surgical strategies. Research into the prevalence, incidence and specific respiratory management strategies in EDS and HSD is needed to mitigate some of the associated morbidity.
Identifiants
pubmed: 34291699
doi: 10.1177/14799731211025313
pmc: PMC8312172
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
14799731211025313Commentaires et corrections
Type : ErratumIn
Références
Ann Thorac Surg. 2014 May;97(5):1804-6
pubmed: 24792277
Case Rep Surg. 2017;2017:2081725
pubmed: 28785503
Arthritis Rheum. 2004 Oct;50(10):3323-8
pubmed: 15476239
Intern Med. 2009;48(9):717-22
pubmed: 19420820
Am J Med Genet A. 2012 Aug;158A(8):2055-70
pubmed: 22786715
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):188-194
pubmed: 28192621
Eur Respir J. 1998 Jan;11(1):139-43
pubmed: 9543283
J Rheumatol. 2000 Jul;27(7):1777-9
pubmed: 10914867
Thorax. 2017 Aug;72(8):729-735
pubmed: 28073822
Interact Cardiovasc Thorac Surg. 2009 Jul;9(1):130-1
pubmed: 19398484
Am J Med. 2003 Jul;115(1):33-40
pubmed: 12867232
Thorax. 2018 Oct;73(10):942-950
pubmed: 29914940
Clin Exp Dermatol. 2016 Oct;41(7):771-4
pubmed: 27663155
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):70-115
pubmed: 28306225
Respir Med Res. 2019 Nov;76:19-21
pubmed: 31476586
Gen Thorac Cardiovasc Surg. 2016 Jul;64(7):425-8
pubmed: 25512090
Ann Thorac Med. 2009 Jul;4(3):115-23
pubmed: 19641641
Clin Genet. 1996 Dec;50(6):510-4
pubmed: 9147885
Am J Med Genet A. 2019 Mar;179(3):356-364
pubmed: 30569502
J Clin Sleep Med. 2019 Feb 15;15(2):293-299
pubmed: 30736885
Am J Med Genet A. 2020 Oct;182(10):2263-2271
pubmed: 32738018
Vasc Endovascular Surg. 2018 Feb;52(2):138-142
pubmed: 29216800
Ir J Med Sci. 1981 Feb;150(2):43-4
pubmed: 7263163
Reumatol Clin (Engl Ed). 2019 Nov - Dec;15(6):e128-e129
pubmed: 29050841
Am J Med Genet A. 2018 Sep;176(9):1838-1844
pubmed: 30063091
Surgery. 1980 Mar;87(3):319-24
pubmed: 6987767
Arch Bronconeumol. 1998 Nov;34(10):512
pubmed: 9881219
Am J Med Genet A. 2019 May;179(5):797-802
pubmed: 30793832
Disabil Rehabil. 2019 Feb;41(4):445-455
pubmed: 29125009
Clin Rev Allergy Immunol. 2020 Jun;58(3):273-297
pubmed: 31267471
BMJ Open. 2019 Nov 4;9(11):e031365
pubmed: 31685485
Medicine (Baltimore). 2017 Nov;96(47):e8853
pubmed: 29381997
Br J Dis Chest. 1981 Jul;75(3):309-10
pubmed: 7295524
J Cardiopulm Rehabil Prev. 2018 May;38(3):198-203
pubmed: 29652761
Am J Med Genet A. 2018 Jan;176(1):251-252
pubmed: 29160015
Int J Otolaryngol. 2012;2012:564852
pubmed: 22577385
Am J Med Genet A. 2010 Mar;152A(3):556-64
pubmed: 20140961
J Hematol Oncol. 2011 Mar 22;4:10
pubmed: 21418662
Cardiol Rev. 2017 Sep/Oct;25(5):247-253
pubmed: 28742547
Clin Genet. 2001 Nov;60(5):360-5
pubmed: 11903337
Case Rep Pulmonol. 2020 Dec 1;2020:8898621
pubmed: 33520324
Plast Reconstr Surg. 2000 Dec;106(7):1520-6
pubmed: 11129180
Pediatr Radiol. 1994;24(4):263-5
pubmed: 7800447
Surgeon. 2005 Feb;3(1):49-51
pubmed: 15789797
Am J Med Genet A. 2013 Dec;161A(12):3005-11
pubmed: 23913726
PLoS One. 2013 Nov 22;8(11):e80321
pubmed: 24278273
Am Surg. 1994 Nov;60(11):827-31
pubmed: 7978674
Eur Respir J. 2017 Aug 10;50(2):
pubmed: 28798087
J Intensive Care Med. 2004 Nov-Dec;19(6):349-51
pubmed: 15523121
PLoS One. 2018 Oct 22;13(10):e0204953
pubmed: 30346958
J Forensic Sci. 2010 Nov;55(6):1641-5
pubmed: 20707836
Best Pract Res Clin Rheumatol. 2008 Mar;22(1):165-89
pubmed: 18328988
Circulation. 1965 Aug;32:193-203
pubmed: 14340945
Br J Rheumatol. 1998 Jul;37(7):803-4
pubmed: 9714368
Respir Med Case Rep. 2014 Dec 24;14:40-2
pubmed: 26029576
Clin Otolaryngol. 2017 Aug;42(4):860-863
pubmed: 27434416
Histopathology. 2010 Jun;56(7):944-50
pubmed: 20500229
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):168-174
pubmed: 28160388
JAMA. 2004 Apr 28;291(16):2013-6
pubmed: 15113821
Thorax. 1985 Apr;40(4):300-5
pubmed: 4023980
Histopathology. 1990 Nov;17(5):478-9
pubmed: 2076877
Ann R Coll Surg Engl. 2012 Jan;94(1):e5-7
pubmed: 22524904
Neurogastroenterol Motil. 2015 Nov;27(11):1657-66
pubmed: 26376608
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26
pubmed: 28306229
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):40-47
pubmed: 28306228
Ann Rheum Dis. 2007 Oct;66(10):1369-73
pubmed: 17412739
Disabil Rehabil. 2017 Jul;39(14):1391-1397
pubmed: 27339264
Intern Med. 2019 Dec 1;58(23):3441-3447
pubmed: 31391389
Ann R Coll Surg Engl. 2015 Apr;97(3):e50-1
pubmed: 26263828
Am J Respir Crit Care Med. 2018 Mar 1;197(5):661-662
pubmed: 29323927
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):148-157
pubmed: 28145606
Lancet. 2010 Oct 30;376(9751):1476-84
pubmed: 20825986
Arch Phys Med Rehabil. 2011 Jul;92(7):1106-12
pubmed: 21636074
BMC Psychiatry. 2016 Jul 04;16:207
pubmed: 27377649
J Emerg Med. 2011 Oct;41(4):366-8
pubmed: 18439794
Am J Med Genet A. 2006 Jan 15;140(2):129-36
pubmed: 16353246
Paediatr Respir Rev. 2006 Jun;7(2):152-60
pubmed: 16765303
Am Rev Respir Dis. 1980 Dec;122(6):971-8
pubmed: 7458068